-
Symbol
-
TRVI on Nasdaq
-
Investment type
-
Equity / Common Stock, $0.001 par value per share
-
Latest Disclosed Ownership
-
15.1M shares
-
Security Ownership
-
12%
New Enterprise Associates 16, L.P. ownership in Trevi Therapeutics, Inc. Common Stock, $0.001 par value per share (TRVI)
2025-08-11 - New Enterprise Associates 16, L.P. has filed an SCHEDULE 13D/A form with the Securities and Exchange Commission (SEC) disclosing ownership of 15.1M shares of Trevi Therapeutics, Inc. Common Stock, $0.001 par value per share (TRVI).
This represents 12% percent ownership of the company.